Investor Deep Dive: ColigoMed

Coligomed, an innovative digital care continuum platform that enables “at-home” care programs end-to-end. ColigoMed is a purpose-built platform designed to empower multi-disciplinary teams, manage complex clinical workflows and successfully drive patient outcomes. In the current healthcare landscape,  care management solutions is a $19.28B opportunity growing at a CAGR of 16%. ColigoMed is sitting at the forefront of disrupting “at-home” care management with  GenAI enabled virtual assistance.

This investor event offers a unique opportunity for you to:

• Gain in-depth knowledge of ColigoMed’s  mission, vision, and solutions
• Explore the immense potential ColigoMed holds for investors
• Engage directly with Naidu and his team to gain insights from his transformative journey

Naidu Annamaneni, the visionary founder of ColigoMed. Naidu is a serial entrepreneur and  technology executive who has several patents in his name and has pioneered AI innovations in several industries. His technology expertise in connecting large data systems together and own personal battles led him to the ColigoMed vision. His vision has already been backed by several high profile physicians, healthcare executives and silicon valley technology executives with a pre-seed funding of over $3M